Page last updated: 2024-11-07

bay r 1531

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Bay R 1531: serotonin-1a receptor agonist [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID127153
CHEMBL ID433084
SCHEMBL ID6890172
MeSH IDM0182906

Synonyms (9)

Synonym
bay r 1531
CHEMBL433084 ,
L004326
SCHEMBL6890172
6-methoxy-n,n-dipropyl-1,3,4,5-tetrahydrobenzo[cd]indol-4-amine
Q4874069
98770-53-7
bdbm50227629
PD128806
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID173458Effect on 5HIAA (5-hydroxyindoleacetic acid) concentration in hypothalamus as an index of serotonin turnover in male Wistar rats expressed as percent of control1988Journal of medicinal chemistry, Sep, Volume: 31, Issue:9
6-substituted 1,3,4,5-tetrahydrobenz[cd]indol-4-amines: potent serotonin agonists.
AID5060Ability to inhibit binding of titreated spiperone to the 5-hydroxytryptamine 2 receptor in rat brain frontal cortex membranes1988Journal of medicinal chemistry, Sep, Volume: 31, Issue:9
6-substituted 1,3,4,5-tetrahydrobenz[cd]indol-4-amines: potent serotonin agonists.
AID3665Ability to inhibit binding of titreated serotonin to the 5-hydroxytryptamine 1 receptor in rat brain frontal cortex membranes1988Journal of medicinal chemistry, Sep, Volume: 31, Issue:9
6-substituted 1,3,4,5-tetrahydrobenz[cd]indol-4-amines: potent serotonin agonists.
AID174302In vivo serum corticosterone concentration in male Wistar rats after injecting 0.3 mg/kg of compound subcutaneously1988Journal of medicinal chemistry, Sep, Volume: 31, Issue:9
6-substituted 1,3,4,5-tetrahydrobenz[cd]indol-4-amines: potent serotonin agonists.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (16.67)18.7374
1990's5 (83.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]